cytarabine and Gasser Syndrome

cytarabine has been researched along with Gasser Syndrome in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, K; Kyohda, K; Matano, S; Matsuda, T; Nakamura, S; Ohtake, S; Okabe, Y; Okumura, H; Yoshida, T1
Carlson, K; Hagberg, H; Oberg, G; Simonsson, B; Smedmyr, B1
Baars, JW; de Glas-Vos, CW; Rodenhuis, S; Thomas, BL; van der Lelie, H; van Dijk, MA; van Oers, RH; von dem Borne, AE1
Aoi, T; Jibiki, M; Kawasaki, T; Kurokawa, H; Nara, N; Shiigai, T; Tohda, S; Ueda, Y1
Halvorson, RD; Raybon, KB; Snyder, MJ1
Ando, M; Ezoe, A; Hirayama, Y; Kohda, K; Kuga, T; Matsumoto, S; Mochizuki, C; Nakazawa, O; Nobuoka, A1

Reviews

1 review(s) available for cytarabine and Gasser Syndrome

ArticleYear
Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support.
    Cancer, 1995, Dec-01, Volume: 76, Issue:11

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Hypertension; Immunoglobulins, Intravenous; Male; Middle Aged; Plasma; Remission Induction; Renal Insufficiency; Retinal Vein Occlusion; Thiotepa; Thrombocytopenia; Transplantation, Autologous; Vincristine

1995

Other Studies

5 other study(ies) available for cytarabine and Gasser Syndrome

ArticleYear
Hemolytic uremic syndrome developing during remission of acute myelomonocytic leukemia.
    American journal of hematology, 1993, Volume: 44, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Hemolytic-Uremic Syndrome; Humans; Leukemia, Myelomonocytic, Acute; Middle Aged; Mitoxantrone; Plasma Exchange; Platelet Aggregation Inhibitors; Prednisolone; Remission Induction; Zinostatin

1993
Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
    Bone marrow transplantation, 1993, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Glomerular Filtration Rate; Hemolytic-Uremic Syndrome; Humans; Kidney; Lymphoma; Male; Middle Aged; Transplantation, Autologous; Whole-Body Irradiation

1993
[Three cases of drug-induced hemolytic uremic syndrome].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Female; Fluorouracil; Gastrointestinal Neoplasms; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin

1996
Hemolytic uremic syndrome after autologous BMT without TBI.
    Bone marrow transplantation, 1996, Volume: 17, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Hemolytic-Uremic Syndrome; Hodgkin Disease; Humans; Male; Transplantation Conditioning; Transplantation, Autologous; Whole-Body Irradiation

1996
Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia.
    International journal of hematology, 1996, Volume: 64, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Hemolytic; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Transplantation; Cytarabine; Fatal Outcome; Female; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunocompromised Host; Immunosuppressive Agents; Lung Diseases, Fungal; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Veno-Occlusive Disease; Retreatment; Transplantation Conditioning

1996